| Literature DB >> 28533722 |
Francesco Bedogni1, Alessandro Frigiola1, Marco Ranucci1, Nedy Brambilla1, Rocco Antonio Montone1, Mauro Agnifili1, Lorenzo Menicanti1, Luca Testa1.
Abstract
Transcatheter aortic valve replacement determined a paradigm shift in the treatment of high-risk patients with severe symptomatic aortic valve stenosis. Notwithstanding the impressive results of the first-generation prostheses, a fast-paced technological evolution is taking place to overcome their limitations, in particular the vascular access damage and the paravalvular leak. Nowadays, with the availability of several different devices, the expert operator can select the right prosthesis for the specific anatomical and clinical situation. As 'One does not fit all', the 'Tailored TAVR Approach' we describe will conceivably become the future of this therapy.Entities:
Year: 2016 PMID: 28533722 DOI: 10.1093/eurheartj/suw017
Source DB: PubMed Journal: Eur Heart J Suppl ISSN: 1520-765X Impact factor: 1.803